🩸Oncosema™️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient.
🩸Oncosema™️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer.
🩸Oncosema™️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use
Oncosema™️ is a registred trade mark of Oncocellex.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 20-22 Rue Henri Et Gilberte Goudier, Zone De La Varenne,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.oncosema.com
- Keywords
- Cancer, Diagnostic, Circulating Tumor Cells, Immunodiagnostic, Liquid Biopsy, Medical research, Patients care, Oncology, Cancerology, IVD, MD, MD IVD.
- HQ
- RIOM
Oncosema Questions
Oncosema's website is http://www.oncosema.com
Oncosema's LinkedIn profile is https://fr.linkedin.com/company/oncosema
Oncosema has
5 employees.
View email and phone details for 5
employees at Oncosema.
Oncosema's industry is
Biotechnology Research
Oncosema's top competitors are
Renaissance Fusion,
Greencell,
Beparentalis,
Gaoma Therapeutics,
D&a Medlabs,
Nexbiome Therapeutics,
Veinsound,
Endodiag,
Osta Therapeutics,
Kairos Discovery.
Oncosema's categories are Biotechnology Research
Oncosema's founding year is 2022
